Medical Journals

Attenuation of Neuroinflammation and Alzheimer's Disease Pathology by Liver X Receptors.

Authors:
  • Zelcer Noam
  • Khanlou Negar
  • Clare Ryan
  • Jiang Qingguang
  • Reed-Geaghan Erin G
  • Landreth Gary E
  • Vinters Harry V
  • Tontonoz Peter

From: Department of Pathology, University of California, Los Angeles, CA 90095, USA.

Proceedings of the National Academy of Sciences of the United States of America

  • Publish Date: Jun 2007
  • ISSN: 0027-8424
  • Volume: 104
  • Issue: 25
  • Pages: 10601-6
  • Medium: Print
  • Language: English
  • Citation (JAMA): Zelcer Noam, Khanlou Negar, Clare Ryan, et al. Attenuation of Neuroinflammation and Alzheimer's Disease Pathology by Liver X Receptors.. Proc. Natl. Acad. Sci. U.S.A. Jun 2007;104:10601-6

Abstract

Alzheimer’s disease (AD) is an age-dependent neurodegenerative disease that causes progressive cognitive impairment. The initiation and progression of AD has been linked to cholesterol metabolism and inflammation, processes that can be modulated by liver x receptors (LXRs). We show here that endogenous LXR signaling impacts the development of AD-related pathology. Genetic loss of either Lxralpha or Lxrbeta in APP/PS1 transgenic mice results in increased amyloid plaque load. LXRs regulate basal and inducible expression of key cholesterol homeostatic genes in the brain and act as potent inhibitors of inflammatory gene expression. Ligand activation of LXRs attenuates the inflammatory response of primary mixed glial cultures to fibrillar amyloid beta peptide (fAbeta) in a receptor-dependent manner. Furthermore, LXRs promote the capacity of microglia to maintain fAbeta-stimulated phagocytosis in the setting of inflammation. These results identify endogenous LXR signaling as an important determinant of AD pathogenesis in mice. We propose that LXRs may be tractable targets for the treatment of AD due to their ability to modulate both lipid metabolic and inflammatory gene expression in the brain.

Mesh Headings (Keywords): Alzheimer Disease, Amyloid beta-Protein, Animals, Brain, Cells, Cultured, Cholesterol, DNA-Binding Proteins, Fluorescent Antibody Technique, Indirect, Gene Expression Regulation, Immunohistochemistry, Inflammation, Lipid Metabolism, Mice, Mice, Inbred C57BL, Mice, Knockout, Mice, Transgenic, Microglia, Phagocytosis, Receptors, Cytoplasmic and Nuclear, Senile Plaques, Signal Transduction


Check for Full Text / PubMed Unique Identifier (PMID): 17563384


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.